Belluscura (BELL) Competitors GBX 9.60 +0.35 (+3.78%) (As of 12/20/2024 11:48 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors BELL vs. CREO, NCYT, IUG, POLX, IHC, AVO, RUA, MHC, SUN, and DEMGShould you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Creo Medical Group (CREO), Novacyt (NCYT), Intelligent Ultrasound Group (IUG), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), and Deltex Medical Group (DEMG). These companies are all part of the "medical devices" industry. Belluscura vs. Creo Medical Group Novacyt Intelligent Ultrasound Group Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences MyHealthChecked Surgical Innovations Group Deltex Medical Group Belluscura (LON:BELL) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings. Does the media favor BELL or CREO? In the previous week, Creo Medical Group had 6 more articles in the media than Belluscura. MarketBeat recorded 6 mentions for Creo Medical Group and 0 mentions for Belluscura. Creo Medical Group's average media sentiment score of 1.22 beat Belluscura's score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the news media. Company Overall Sentiment Belluscura Neutral Creo Medical Group Positive Do institutionals and insiders have more ownership in BELL or CREO? 6.3% of Belluscura shares are owned by institutional investors. Comparatively, 56.1% of Creo Medical Group shares are owned by institutional investors. 56.3% of Belluscura shares are owned by company insiders. Comparatively, 22.4% of Creo Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, BELL or CREO? Belluscura has higher earnings, but lower revenue than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBelluscura£1.80M8.98-£18.60M-£0.10-96.00Creo Medical Group£30.30M2.33-£22.40M-£0.06-325.00 Which has more risk and volatility, BELL or CREO? Belluscura has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Does the MarketBeat Community favor BELL or CREO? Creo Medical Group received 106 more outperform votes than Belluscura when rated by MarketBeat users. CompanyUnderperformOutperformBelluscuraN/AN/ACreo Medical GroupOutperform Votes10667.52% Underperform Votes5132.48% Is BELL or CREO more profitable? Belluscura has a net margin of 0.00% compared to Creo Medical Group's net margin of -73.93%. Creo Medical Group's return on equity of -38.49% beat Belluscura's return on equity.Company Net Margins Return on Equity Return on Assets BelluscuraN/A -85.01% -43.53% Creo Medical Group -73.93%-38.49%-20.09% SummaryCreo Medical Group beats Belluscura on 8 of the 14 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Belluscura News Delivered to You Automatically Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BELL vs. The Competition Export to ExcelMetricBelluscuraMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£16.17M£2.25B£5.12B£1.69BDividend YieldN/A2.37%4.91%11.86%P/E Ratio-96.00214.9991.341,664.81Price / Sales8.98200.841,116.59347,854.21Price / Cash8.0015.3842.6438.18Price / Book0.804.214.792.82Net Income-£18.60M£77.46M£120.07M£149.84M7 Day PerformanceN/A-0.15%-1.89%-1.79%1 Month Performance1.05%12.04%11.45%15.93%1 Year Performance-56.36%10.28%30.61%26.94% Belluscura Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BELLBelluscuraN/AGBX 9.60+3.8%N/A-56.4%£16.17M£1.80M-96.0024Gap UpCREOCreo Medical GroupN/AGBX 17.50+3.7%N/A-46.6%£63.31M£30.30M-291.67279News CoveragePositive NewsNCYTNovacytN/AGBX 51.80-9.0%N/A-18.7%£36.59M£18.56M-99.62120IUGIntelligent Ultrasound GroupN/AGBX 10.88flatN/A+31.0%£35.57M£9.88M-1,087.5065News CoveragePOLXPolarean ImagingN/AGBX 1.35flatN/A-80.1%£16.34M£1.87M-67.5028IHCInspiration Healthcare GroupN/AGBX 12.75-5.6%N/A-66.1%£11.43M£34.30M-91.07224Gap DownHigh Trading VolumeAVOAdvanced OncotherapyN/AGBX 1.75-9.1%N/A+0.0%£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11+3.6%N/A+7.9%£6.83M£2.19M-275.0048MHCMyHealthCheckedN/AGBX 11.25flatN/A+8.4%£5.85M£9.39M-562.5016Gap DownSUNSurgical Innovations GroupN/AGBX 0.55flatN/A-11.5%£5.13M£12.54M-21.1180News CoverageDEMGDeltex Medical GroupN/AGBX 0.08flatN/A-50.3%£1.52M£1.78M-5.7537 Related Companies and Tools Related Companies CREO Competitors NCYT Competitors IUG Competitors POLX Competitors IHC Competitors AVO Competitors RUA Competitors MHC Competitors SUN Competitors DEMG Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:BELL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belluscura plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Belluscura With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BELL Stock Alerts